Home/Filings/4/0001179110-15-008099
4//SEC Filing

ABIOMED INC 4

Accession 0001179110-15-008099

CIK 0000815094operating

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:48 PM ET

Size

15.4 KB

Accession

0001179110-15-008099

Insider Transaction Report

Form 4
Period: 2015-05-15
Bowen Robert
Chief Financial Officer
Transactions
  • Sale

    Common Stock, $.01 par value

    2015-05-15$67.65/sh5,637$381,32476,850 total
  • Sale

    Common Stock, $.01 par value

    2015-05-15$68.46/sh585$40,04776,265 total
Holdings
  • Stock Option (right to buy)

    Exercise: $10.03From: 2011-06-03Exp: 2020-06-03Common Stock (7,500 underlying)
    7,500
  • Stock Option (Right to Buy)

    Exercise: $15.92From: 2009-12-22Exp: 2018-12-22Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $22.44From: 2013-05-22Exp: 2023-05-22Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy)

    Exercise: $23.15From: 2014-05-14Exp: 2024-05-14Common Stock (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
  • [F3]Sale of common stock pursuant to reporting owner's 10b5-1 plan, including for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
  • [F4]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.0200 and $68.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F5]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.0200 and $68.6350. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Issuer

ABIOMED INC

CIK 0000815094

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000815094

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:48 PM ET
Size
15.4 KB